Ms. Remillard has over 25 years of experience providing worldwide patent counseling and strategic planning, including patent prosecution, freedom to operate evaluations, opinion work, financial offerings, agreements, licensing, due diligence, interferences, re-examinations, reissues, inter-partes reviews, and oppositions involving a variety of biotechnologies, particularly antibody-based therapeutics
Ms. Remillard’s practice involves developing and implementing effective IP strategies, including building strong patent portfolios to protect and facilitate commercialization of products, and assessing freedom to operate for a broad range of clients, from start-up biotechnology companies to established pharmaceutical corporations
Ms. Remillard has extensive experience conducting due diligence evaluations for pharmaceutical and biotechnology collaborations, acquisitions, licensing, and financing transactions. She also represents clients in private and public offerings, both in the United States and abroad. She advises investors in assessing the strength of intellectual property assets held by prospective candidates for investment.